SomaLogic, OncoHost announce license agreement for the development of precision cancer diagnostics

Pangea Biomed, OHSU Knight Cancer Institute collaborate to improve cancer therapy precision

Pangea Biomed, a startup developing the Enlight cancer response prediction platform, announced the beginning of a pilot collaboration with the Knight Cancer Institute at Oregon Health and Science University.

November 01, 2024

Vol.50 No.41

Clinical Roundup

Research shows applications of novel cfDNA approach in precision medicine

Research published in Communications Biology demonstrates the potential of Aqtual’s proprietary platform that evaluates gene regulation, epigenetics, and transcriptomics by analyzing previously unexplored cfDNA fragments found in blood, opening the door to novel clinical applications in almost every major disease area.

September 13, 2024

Vol.50 No.34

In Brief

Lei Zheng named executive director of Mays Cancer Center

Lei Zheng was named executive director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, and vice president for oncology for the University of Texas Health Science Center at San Antonio.

July 12, 2024

Vol.50 No.28

In Brief

Mark Burkard named director of UI Health Care Holden Comprehensive Cancer Center

Mark Burkard was named director of University of Iowa Health Care Holden Comprehensive Cancer Center.

July 12, 2024

Vol.50 No.28

Drugs & Targets

Parexel releases report on advancing precision oncology

Parexel, one of the world’s largest clinical research organizations providing the full range of phase I to IV clinical development services, has released a new report in their expert series, New Medicines, Novel Insights.

May 24, 2024

Vol.50 No.21

Clinical Trials & Tribulations

Single-cell based precision oncology: First steps in addressing and overcoming tumor heterogeneity

Tumor heterogeneity is a well-recognized hurdle to successful cancer therapy, often leading to resistance and treatment failure.

May 10, 2024

Vol.50 No.19

By Sanju Sinha and Eytan Ruppin

SomaLogic, OncoHost announce license agreement for the development of precision cancer diagnostics

YOU MAY BE INTERESTED IN

Pangea Biomed, OHSU Knight Cancer Institute collaborate to improve cancer therapy precision

Research shows applications of novel cfDNA approach in precision medicine

Lei Zheng named executive director of Mays Cancer Center

Mark Burkard named director of UI Health Care Holden Comprehensive Cancer Center

Parexel releases report on advancing precision oncology

Single-cell based precision oncology: First steps in addressing and overcoming tumor heterogeneity

Renew today!

Subscriber content

Login